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Shanghai 200092, ChinaAbstract—Mental and neurological illnesses aﬀect one in
four people. While genetic linkage analyses have shown
an association of nuclear distribution factor E (NDE1, or
NudE) and its ohnolog NDE-like 1 (NDEL1, or Nudel) with
mental disorders, the cellular mechanisms remain unclear.
In the present study, we have demonstrated that Nde1 and
Ndel1 are diﬀerentially localised in the subventricular zone
(SVZ) of the forebrain and the subgranular zone (SGZ) of
the hippocampus, two regions where neurogenesis actively
occurs in the adult brain. Nde1, but not Ndel1, is localized to
putative SVZ stem cells, and to actively dividing progenitors
of the SGZ. The inﬂuence of these proteins on neural stem
cell diﬀerentiation was investigated by overexpression in a
hippocampal neural stem cell line, HCN-A94. Increasing
Nde1 expression in this neural stem cell line led to increased
neuronal diﬀerentiation while decreasing levels of astroglial
diﬀerentiation. In primary cultured neurons and astrocytes,
Nde1 and Ndel1 were found to have diﬀerent but comparable
subcellular localizations. In addition, we have shown for the
ﬁrst time that Nde1 is heterogeneously distributed in corti-
cal astrocytes of human brains. Our data indicate that
Nde1 and Ndel1 have distinct but overlapping distribution
patterns in mouse brain and cultured nerve cells. They
may function diﬀerently and therefore their dosage changes
may contribute to some aspects of mental disorders.
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INTRODUCTION
Nuclear distribution factor E (Nde1, or NudE) and nuclear
distribution factor E-like (Ndel1, or Nudel) are ohnologous,
evolutionarily conserved proteins with more than 50%
amino acid conservation (Sweeney et al., 2001). They
are coiled-coil proteins that can form a complex by binding
lissencephaly-1 (LIS1) (Derewenda et al., 2007), and can
also interact with dynein. They are essential for the func-
tion of microtubules which regulate cell mitosis and migra-
tion (McKenney et al., 2010). Nde1 and Ndel1 are both
critical for cortical development. They regulate develop-
mental neurogenesis and cortical neuronal positioning
(Shu et al., 2004; Tsai et al., 2005, 2007). For example,
NDE1 mutations in humans can cause lissencephaly, a
cortical developmental disease, and overt microcephaly
(Alkuraya et al., 2011; Bakircioglu et al., 2011). Targeted
deletion of Nde1 in mice is often embryonically or postna-
tally lethal and the mice have fewer cortical neurons and a
much thinner cortex, reminiscent of lissencephaly. Muta-
tion in Nde1 reduces the neural progenitor pool, dramati-
cally inhibits later stage neuronal migration and blocks
the development of the upper cortical layers (Feng et al.,
2000; Feng and Walsh, 2004). Ndel1-null mutant mice
are also embryonic lethal – Ndel1/ embryos die shortly
after implantation. Ndel1 null/hypomorph compound het-
erozygotes (Ndel1cko/) exhibit mild neuronal migration
defects (Shu et al., 2004; Sasaki et al., 2005). In addition,
Ndel1 can be phosphorylated by Aurora A kinase at posi-
tion S251 or by the Cdk1/Cdk5 kinase at positions T219/
T245, which are important for the interaction with dynein
(Zylkiewicz et al., 2011) and for the regulation of neuronal
migration (Mori et al., 2007).
The investigation of copy number variation (CNV) of
NDE1 and NDEL1 strongly suggests that they are
associated with neuropsychiatric disorders. In genetic
association studies, NDE1 has been identiﬁed as a
strong candidate for epilepsy (Heinzen et al., 2010) and
schizophrenia (Ekholm et al., 2003; Hennah et al., 2007;
Ingason et al., 2011). The Disrupted in schizophrenia 1
(DISC1) protein is a common binding partner of NDE1
and NDEL1. Both NDEL1 and DISC1 are important
genetic risk factors for the development of schizophrenia
(Ozeki et al., 2003; Burdick et al., 2008), and they are all
involved in regulating the migration of newly generated
neurons in the adult hippocampus. Downregulation of/licenses/by/3.0/).
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(SGZ) led to the formation of ectopic primary dendrites
and mispositioning of the soma during neuronal matura-
tion (Duan et al., 2007). Although Nde1 is involved in
epilepsy, and adult hippocampal neurogenesis is
up-regulated in rodent epilepsy models (Bengzon et al.,
1997; Parent et al., 1997; Jessberger et al., 2007) and
after antidepressant treatment (Malberg et al., 2000; Reif
et al., 2006), the roles of Nde1 in these processes are less
intensively investigated and therefore remains unclear.
Intriguingly, although there are several sporadic
reports in the embryonic mouse and human cortex
(Bakircioglu et al., 2011; Pawlisz and Feng, 2011), little
information for the localization of Nde1 and Ndel1 in the
developing and adult brains is available. It is essential to
perform more wide and detailed investigations of the
expression pattern of Nde1 and Ndel1 in the adult brain.
For instance, its expression and dysfunction in astrocytes
might play important roles in neurological disorders
including epilepsy (Blumcke et al., 2002; de Lanerolle
and Lee, 2005; Seifert and Steinhauser, 2013) and
schizophrenia (Rothermundt et al., 2004). Although
NDE1 and NDEL1 have been shown to be expressed in
some human gliomas, their expression in normal astro-
cytes has not been well described.
In the present study, we have performed a
comprehensive regional comparison of the expression
proﬁles of Nde1 and Ndel1 in the adult mouse brain,
with emphasis on the subventricular zone (SVZ) in the
forebrain and the SGZ in the hippocampus, two regions
where adult neural stem cells reside. We also analyzed
the distribution and function of Nde1 and Ndel1 in
primary neuronal/glia culture and a hippocampal neural
stem cell line, HCN-A94. Our further functional studies
suggest that overexpression of Nde1 and Ndel1 play
important roles in cell fate speciﬁcation, which
potentially links with a range of neurodevelopmental and
neuropsychiatric disorders.EXPERIMENTAL PROCEDURES
Animals and section preparation
All the animal work was approved by the Local Ethics
Review Board of the University of Aberdeen. All animal
procedures were performed with UK Home Oﬃce
licence under the Animals (Scientiﬁc Procedures) Act
1986, with guidance of the Medical Research Facility,
Aberdeen University, UK. Particular care was taken to
minimize the number of animals to achieve statistical
signiﬁcance. Human brain tissue work in the present
study was approved by the Ethics Committee of
Universidade Metropolitana de Santos, SP, Brazil and
by the Brazilian Health Research Committee on 4th of
April 2011, under the number CONEP 16168,
documents registered under the number 25000.169694/
2010-18. Human brain tissue samples were collected
from prefrontal, frontal and temporal cortices of adult
male individuals aged 55 years or less at the Guilherme
Alvaro Hospital, Santos, SP, Brazil, with written consent
from the relatives of the deceased. None of the subjects
presented a major neurological or psychiatric conditionduring life and the cause of death excluded head
trauma, brain infection and stroke.
For immunohistochemistry, the brains of adult C57BL/
6J mice were dissected out, embedded in Optimal Cutting
Temperature compound (OCT) and snap-frozen on dry
ice (n= 3). Serial coronal sections with thickness of
12 lm were yielded in a cryostat (Leica, CM1850,
Germany) and mounted on the poly-lysine-coated slices
(VWR, UK). These sections were stored in 80 C just
before use.
Immunohistochemistry
Mouse brain sections were post-ﬁxed in 4%
paraformaldehyde (pH 7.4) for 5 min and washed with
phosphate-buﬀered saline (PBS). Antigen retrieval was
carried out by incubation in 0.01 M sodium citrate buﬀer
(pH 6.0) and microwaving (800 W, 6 min). Non-speciﬁc
immunoreactivity was suppressed by incubating
samples in 5% bovine serum albumin (BSA) (Sigma,
UK) and 5% serum of the species which generated the
secondary antibody. For immunoﬂuorescent staining,
the following primary antibodies were used: mouse anti-
GAD67 (1:1000; Millipore, US), mouse anti-GFAP
(1:1000; Abcam, UK), rabbit anti-GFAP (1:2000; DAKO,
Denmark), rat anti-Ki67 (1:100; DAKO, Denmark),
mouse anti-MAP2 (1:3000; Sigma, UK), rabbit anti-
MAP2 (1:200; Cell Signalling, US), rabbit anti-Nudel
(1:400; Abcam, UK), rabbit anti-Nde1 (1:400; Sigma,
UK), goat anti-Ndel1 (1:400; Sigma, UK), mouse anti-
Nestin (1:200; Abcam, UK), mouse anti-NeuN (1:400;
Millipore, US), goat anti-SOX2 (1:200; Santa Cruz, US),
mouse anti-Vimentin (1:100; DSHB, US), rabbit anti-b
tubulin III (1:3000; Sigma, UK) and mouse anti-b tubulin
III (1:3000; Sigma, UK). The primary antibodies were
diluted in PBS with 3% BSA plus 0.1% Triton X-100 and
applied for 24 h at 4 C. Sections were then incubated
with diﬀerent combinations of ﬂuorescent-conjugated
secondary antibodies (Molecular Probes, US), which
included Alexa 488-conjugated donkey anti-goat,
donkey anti-rabbit, donkey anti-mouse and goat anti-
mouse IgG; Alexa 594-conjugated donkey anti-goat,
donkey anti-mouse, donkey anti-rabbit and donkey anti-
rat IgG; and Cy3-conjugated donkey anti mouse IgM.
The sections were ﬁnally counterstained with Hoechst
33258 (Molecular Probes, US).
To visualize the immunoreactivity, some sections
were incubated with biotin-conjugated secondary
antibodies (Sigma, UK) followed by Vectastain Elite
avidin/biotin complex reagent (Vector Laboratories, UK)
according to the manufacturer’s instructions. After being
washed with PBS, immunoreaction was visualized with
3,30-diaminobenzidine (Sigma, UK). One of each series
of the immunostained sections was counterstained with
cresyl violet for the study of cytoarchitecture. Internal
standards were employed to evaluate the intensity of
immunostaining semi-quantitatively by two independent
researchers without the knowledge of the experiment.
The intensity of immunoreactivity was categorized as
intense (+++), moderate (++), weak (+) and
negative (), which represented the relative expression
levels among diﬀerent regions and had no indication of
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was performed with the same protocol except that the
primary antibodies were replaced with normal IgG from
the same animal species. The anatomical nomenclature
of Paxinos and Watson (1986) was adopted to describe
the regions of the CNS.
Immunoﬂuorescence staining was also performed on
7-lm thick human prefrontal, frontal and temporal
sections prepared from formalin-ﬁxed and paraﬃn-
embedded blocks. Sections were de-waxed in histoclear
(National Diagnostics, US) and rehydrated through
decreasing ethanol concentrations (100%, 95%, 80% and
70%). Antigen retrieval was carried out by incubating
sections in sodium citrate buﬀer (pH 6.0) and
microwaving (800 W, 6 min) followed by incubation in ice-
cold NaHBO4 (0.5%, in 0.1 M pH 7.4 phosphate buﬀer,
10 min). Blocking and subsequent steps followed the
same protocol as for mouse tissue ﬂuorescence staining.
Lipofuscin autoﬂuorescence was quenched by applying
Sudan Black-B (1% in 70% ethanol). The samples were
then mounted in Aquamount (DAKO, Denmark).Western blotting
Adult mouse brains were dissected into seven parts:
olfactory bulb (OB), cortex (Ctx), thalamus (Tha),
hippocampus (Hp), cerebellum (Cereb, Cb), pons and
spinal cord (Sp). Tissue samples were lysed in cell lysis
buﬀer (Cell Signaling, US) containing a cocktail of
protease inhibitors (Complete, Roche, UK). The lysates
were analyzed by 14% sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS–PAGE) (15 lg
protein/sample). Membranes were blocked in skimmed
milk for 1 h and exposed to the primary antibodies
overnight at 4 C. The primary antibodies are rabbit anti-
Nudel (1:1000; Abcam, UK), rabbit anti-Nde1 (1:1000;
Sigma, UK), goat anti-Ndel1 (1:1000; Sigma, UK).
Mouse anti-GAPDH (1:10,000, Santa Cruz, US) or
mouse anti-a-tubulin (1:50,000; Sigma, UK) were used
as loading controls. After secondary antibody incubation
(1 h), the membranes were developed by an enhanced
chemiluminescence kit (Millipore, US).In vitro over-expression of Nde1/Ndel1
Rat Nde1 or Ndel1 coding sequences (CDS) were
reverse-transcription polymerase chain reaction (RT-
PCR)-ampliﬁed from mRNA and inserted independently
into the pEGFP-C1 vector (Clontech, US) between the
BspEI and SalI restriction sites. For Nde1, the following
primers were used: forward (BspEI site), 50-GCC-
TCCGGA-ATGGAGGACTCGGGAAAGACTT-30; reverse
(include SalI site), 50-GGT-GTCGAC-GCAGTTCCCACT
GGTCCTAAAGC-30. For Ndel1, forward (include SalI
site), 50-TTC-GTCGAC-ATGGATGGTGAAGATATACCG
GAT-30; reverse (include BamHI site), 50-ACC-GGATC
C-CCGAGGGACGAGGCGTA-30. Untreated pEGFP-C1
vectors were prepared for negative control. All the
constructs were sequenced to conﬁrm integrity.
The HCN-A94 cell line was a gift from Prof. Fred H.
Gage (Salk Institute, US) and was maintained as
described (Gage et al., 1995; Shen et al., 2011). DMEMmedium with 0.5% fetal bovine serum (FBS), 1 lM trans-
retinoic acid and N-2 (Invitrogen, US) were used for diﬀer-
entiation. To achieve in vitro overexpression,
undiﬀerentiated HCN-A94 cells were transfected with
the pCMV-Nde1-EGFP, pCMV-Ndel1-EGFP or empty
pCMV-EGFP vectors by using the rat neural stem cell
Nucleofector kit (Lonza, UK). From the second day after
transfection, the expression of constructs was maintained
by applying selective antibiotic G418 (Sigma, 400 lg/ml)
into the culture. The same dose of G418 also was used
during the process of diﬀerentiation.Primary culture and immunocytochemistry
Mouse (C57BL/6) cortices and hippocampi were
dissected at the embryonic stage E18.5. Neuronal and
glial primary culture was established as described
previously (Viesselmann et al., 2011). Primary neuronal
cells were maintained in Neurobasal-A medium (Invitro-
gen) supplemented with GlutaMax (Invitrogen, US) and
B27 (Invitrogen, US) up to the time points of analysis
(24 h, day 2, day 4, day 7). Primary astrocytes were pla-
ted on poly-L-lysine-coated glass coverslips (13 mm,
VWR, UK) at a density of 3000 cells per ml and main-
tained in DMEM-F12 medium with 10% FBS. They were
cultured for two weeks before analysis.
Both the HCN-A94 cell lines and the primary cultured
neurons/astrocytes were ﬁxed in paraformaldehyde (4%)
for 5 min, permeabilized in 20 C methanol for 2–3 min
and treated with blocking buﬀer (5% donkey serum,
0.3% Triton X-100 in PBS) at room temperature for 1 h.
Immunoﬂuorescence and negative staining were
performed using the same protocol as mouse tissue
staining.mRNA analysis by RT-PCR
RNA of undiﬀerentiated HCN-A94 cells was isolated with
the Total RNA Kit (Peqlab, UK) and was DNaseI- (Roche,
UK) digested according to the manufacturers’
instructions. cDNA was synthesised by using SuperScript
II (Invitrogen, US) and oligo dT12–18 primer (Amersham
Biosciences, UK). Ampliﬁcation was performed with 1 ng
cDNA or the same volume control samples. The
following primers were used: for Nde1, forward: 50-TGG
CCCAGTCCCTAGCAGTGG-30; reverse: 50-GGCCAGT
CCAACGCAAGCTGT-30; for Ndel1, forward: 50-GGCGG
CGAACATGCGCTTTT-30; reverse, 50-TGTTGCCCG
TTTTGCTCGCT-30. The annealing temperature was
60 C.Quantitative-RT PCR analysis of human cortical
samples
Samples of human prefrontal, frontal and temporal cortex
were collected in RNAlater RNA Stabilization Reagent
(Qiagen, Venlo, The Netherlands) and stored at 4 C for
qPCR. RNA extraction and quantitative PCR (qPCR)
analysis followed our previously published protocols
(Fragoso et al., 2012). The following primers were used.
For NDE1: forward, 30-AGCCAGAGATTTGCGGCAG-
GAAC-50; reverse: 30-CCTCGGTGAGCAATGGGCGT-
Fig. 1. Distribution of Nde1 and Ndel1 in the adult mouse CNS. (A–B) Immunohistochemical staining shows that Nde1 (A1–A6) and Ndel1 (B1–B6)
are distributed widely in adult mouse CNS. Arrows in A3 and B3 indicate the lateral ventricle area. Arrows in A4, B4 show the granular layer of
dentate gyrus. Arrows in A5 and B5 show the Purkinje cell layer. Arrows in A5 and B5 indicate the central canals in the cervical spinal cord.
Strongest staining was also found in projecting nerves and the major white matter tracts. Negative controls showed only faint background staining
after overdevelopment. I–VI, sublayers of cortex; cc in B3, corpus callosum; cc in A6 and B6, central canal; Cereb, cerebellum; CPu, caudate
putamen; Ctx, cortex; cu, cuneate fasciculus; DG, dentate gyrus; MI, mitral cell layer; EPI, external plexiform layer; gr, gracile fasciculus; Hp,
hippocampus; IPI, internal plexiform layer; LV, lateral Ventricle; OB, olfactory bulb; Puj, purkinje cell layer; py, pyramidal tract; SP, spinal cord. Scale
bar = 100 lm.
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TAGGGGCTT-50; reverse, 30-GCCATTGCCATTCAG-
CACCCC-50. The annealing temperature was 60 C.Image analysis
To quantify neural and astrocytic diﬀerentiation ratio in
over-expression experiments, ﬁfteen microscopic ﬁelds
(10 objective) were picked randomly in each sample
and the number of GFP single-labeled cells, GFAP/GFP
double-labeled cells or Tuj1/GFP double-labeled cells
were counted in each ﬁeld. The proportion of
diﬀerentiated astrocytes with GFP was calculated by the
number of GFAP/GFP double-labeled cells against the
total number of GFP single-labeled cells. The proportion
of neuronal diﬀerentiation was presented by the ratio of
the number of Tuj1/GFP double-labeled cells against
the total number of GFP single-labeled cells. Thenumber of total GFP-positive cells is larger than 10,000
in each group. The experiment was repeated three
times. Results of Nde1-overexpressing group or Ndel1-
overexpressing group were compared independently
with the pCMV-EGFP vector-transfected group
(negative control).
To quantify the NDE1 expression ratio in astrocytes of
white matter or gray matter in the human cortex, two
diﬀerent cortical sections were taken from each donor.
Ten to ﬁfteen microscopy ﬁelds (10 objective) were
taken randomly in gray matter or white matter and the
number of NDE/GFAP double-labeled and GFAP single-
labeled cells was counted. For each section, the number
of NDE/GFAP double-labeled cells was divided by the
number of GFAP single-labeled cells. The results were
then analyzed between gray matter and white matter by
the Mann–Whitney U test. p< 0.05 was considered as
signiﬁcantly diﬀerent.
Fig. 2. Western blot analysis of Nde1 and Ndel1 proﬁles. (A)
Immunoblotting was carried out on lysates from diﬀerent sub-regions
of the adult mouse brain and robust expression of Nde1 (39 kDa) and
Ndel1 (39 kDa) were detected. (B) Lysates of the adult mouse cortex
(two independent lanes for each antibody) were blotted with anti-
Nde1 (Ab25959, Abcam, left lane), anti-Nde1 (HPA018536, Sigma,
middle lane) and anti-Ndel1 (SAB2500676, Sigma, right lane). These
antibodies all detected one band of the same size which highlighted
their unique speciﬁcities. (C) Cell lysates from NIH3T3 cells tran-
siently transfected with pCMV-EGFP (left lane) or with pCMV-Ndel1-
EGFP (middle lane) or with pCMV-Nde1-EGFP (right lane) were
subject to the blotting with anti-Nde1 (HPA018536, top) or anti-Ndel1
(SAB2500676, bottom). Ndel1 antibody detected abundant Ndel1
expression in 3T3 cells, whereas Nde1 antibody showed little
expression of Nde1 in 3T3 cells. Little or no cross-reaction between
anti-Nde1 and Ndel1 further conﬁrmed the speciﬁcity of these two
antibodies. Several extra bands were also detected underneath
Nde1-EGFP fusion protein in top panel of C. They were likely the
degraded products of the fusion protein during protein preparation.
Arrows indicate EGFP fusion proteins.
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Expression of Nde1 and Ndel1 in the adult mouse
CNS
Although Nde1 and Ndel1 play important roles in
neurodevelopment and neuropsychiatry, little information
is available about their expression and distribution in the
adult brain. We therefore performed immunohisto-
chemical studies and investigated the detailed
localization of Nde1 and Ndel1 in adult mouse brains.
Nde1 and Ndel1 were found widely distributed in the
CNS of adult mice. Their distribution patterns were
similar but not identical (Fig. 1). Immunodouble-labelingshowed that both proteins were largely co-expressed
with the neuronal marker NeuN in CNS (Fig. 4C, D, I).
In the olfactory bulb, Nde1 and Ndel1 were strongly
expressed within the internal/external plexiform layers,
mitral cell layer and granular cell layer (Fig. 1A1, B1).
They were also detected in most cortical neuronal cells
(Fig. 1A2, B2), the lateral ventricle regions (especially
for Nde1, Fig. 1A3) and in the hippocampus (Fig. 1A4,
B4). Nde1 and Ndel1 proteins were not detected to the
same intensity in all brain regions. For example, in the
hippocampus, Nde1 was present at high levels in CA1–
3, the dentate gyrus granular cell layer (arrowed) and
the polymorph layer. In contrast, though Ndel1 staining
revealed a slightly higher expression in the polymorph
layer, Ndel1 is only moderately expressed in CA1–3 and
dentate gyrus (Fig. 1A4, B4, arrowed). In the
cerebellum, somatic expression was most abundant in
Purkinje neurons (Fig. 1A5, B5, arrows). Both proteins
were broadly and strongly localized in white matter
tracts, and projecting nerves, including in the spinal cord
(Fig. 1A6, B6). We further performed western blotting
assays and also detected robust expression of Nde1
and Ndel1 in diﬀerent brain sub-regions (Fig. 2). Two
antibodies against diﬀerent peptide sequences of Nde1
were used and the results were consistent. A detailed
summary of the distribution of Nde1 and Ndel1 proteins
in the mouse CNS is given in Table 1.Distribution of Nde1 and Ndel1 in the adult mouse
SVZ
Because Nde1 functions in stem cell mitosis (Feng and
Walsh, 2004), we hypothesized that Nde1 may be
expressed in the adult stem cells of SVZ in vivo. Two sub-
types of SVZ neural progenitors have been identiﬁed so
far: (1) infrequently or slowly dividing type B cells (putative
stem cells) which are GFAP-positive and share some
characteristics with radial glia; (2) type C active mitotic
cells (Suh et al., 2009) which express Ki67 instead of
GFAP. Our results showed that Nde1 (not Ndel1) was
extensively expressed in the adult mouse SVZ (Fig. 3),
and weakly co-localized with Ki67, a proliferation marker
for actively dividing cells in the SVZ (Fig. 3). There was
no co-localization of Nde1 and NeuN, markers for mature
neurons, in the SVZ (Fig. 3C, D). In addition, some of the
Nde1-stained cells had a unique radial process (Fig. 3D,
white arrows) which may indicate astrocytic or stem cell
morphology. We speculated that the Nde1-expressing
cells may include type B stem cells. GFAP staining was
carried out and the co-expression of GFAP/Nde1 was
conﬁrmed (Fig. 3E–G, white arrows). These results sug-
gest that Nde1 may be localized to SVZ-type B stem cells.
In contrast, Ndel1 was barely detectable in the SVZ of the
lateral ventricle (Fig. 3H, I), which suggested that Ndel1 is
probably not expressed in SVZ adult stem cells at a signif-
icant level.High levels of Nde1 in adult SGZ
We then examined the expression pattern of Nde1 and
Ndel1 in the hippocampal SGZ, another niche where
adult stem cells reside (Christian et al., 2010), and found
Fig. 3. Distribution proﬁles of Nde1 and Ndel1 in the adult SVZ. (A, B) Immunohistochemistry of adult mouse brain slices showed that Nde1 but not
Ndel1 is distributed widely in the SVZ. Nde1 also is expressed weakly in Ki67-positive cells (white arrows). (C, D) Nde1-positive cells in the SVZ are
not NeuN-expressing mature neurons. Some of these cells have long processes which contained Nde1 (white arrows). (E–G) Subsets of Nde1-
positive cells in SVZ also express GFAP (white arrows). (H, I) Ndel1 is not highly expressed in the SVZ and is not co-expressed with GFAP in this
region. cc, corpus callosum; cp, choroid plexus; CPu, caudate putamen; LV, lateral ventricle; LSV, lateral septal nucleus, ventral; aSVZ, anterior
subventricular zone; Scale bar = 20 lm in A–D, H, and I; 25 lm in E–G.
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Nde1 was expressed in Ki67-positive cells in the SGZ
(Fig. 4D). In contrast, there was no or only very weakco-localization of Ndel1 and Ki67 in the same brain region
(Fig. 4E). Sox2, a stem cell marker, also was co-
expressed in a subset of Nde1-positive cells in the SGZ
Fig. 4. The distribution of Nde1 and Ndel1 in the subgranular zone (SGZ) of the adult hippocampus. (A, B) Immunostaining of the adult mouse
hippocampus. Nde1 is highly expressed in both the polymorph layer and granular layer of the dentate gyrus (A); Ndel1 is more highly localized to the
somata of some polymorph layer cells, but is also expressed in the granular layer of the dentate gyrus (B). (C) RT-PCR reveals more expression of
Nde1 mRNA than Ndel1 mRNA in undiﬀerentiated HCN-A94 cells. (D, E) In the SGZ, Ki67-labeled putative stem cells also express Nde1 (D) but not
Ndel1 (E). (F) Double-labeling of Nde1 and Sox2 shows that Sox2-labeled adult stem cells also express Nde1. (G–L) Immunocytochemistry of
undiﬀerentiated HCN-A94 cells revealed high expression of Nde1 (G–I) and low expression of Ndel1 (J–L). PoDG, polymorph layer, dentate gyrus;
GrDG, granular layer of the dentate gyrus; Ctl, negative control; Scale bar = 20 lm.
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expressed in actively dividing adult stem cells in the
SGZ region.
To conﬁrm the potential expression of Nde1 in SGZ
adult stem cells, we performed immunocytochemistry
and RT-PCR assays in HCN-A94 cells, an adult rat
hippocampal neural stem cell line (Gage et al., 1995;
Shen et al., 2011). High levels of Nde1 were found in
undiﬀerentiated HCN-A94 cells and intriguingly, these
Nde1-expressing cells consistently showed co-immuno-
staining of Nestin, a speciﬁc marker for neural stem cells
(Fig. 4G–I). In contrast, weak expression of Ndel1 was
detected in these cells (Fig. 4J–L). Similar mRNA
expression proﬁle was detected by RT-PCR (Fig. 4C).
We therefore concluded that Nde1 but not Ndel1 is abun-
dantly expressed in adult hippocampal progenitor (stem)
cells.Nde1 overexpression decreases astrocytic
diﬀerentiation of HCN-A94 cells
The diﬀerent expression patterns of Nde1 and Ndel1 in
the adult mouse hippocampus suggest that Nde1 and
Ndel1 may have diﬀerent functions during adult
neurogenesis. In order to examine the precise functions
of Nde1 and Ndel1 in adult hippocampal stem cells, and
to determine how CNV of Nde1 and Ndel1 in the human
population may underlie abnormal brain development,
we have generated speciﬁc plasmids to over-express rat
full length Nde1 or Ndel1 and performed the transfection
experiments. Using the pCMV-EGFP, pCMV-Nde1-
EGFP or pCMV-Ndel1-EGFP expression constructs
described earlier, each gene was transiently over-
expressed independently in undiﬀerentiated HCN-A94
cells and protein up-regulation was detected by
Table 1. The distribution of Nde1 and Ndel1 in the mouse CNS
Observed regions Intensity
Main olfactory bulb
EPI (external plexiform layer of the olfactory
bulb)
+ +
GA (granular layer) + 
Gl (glomerular layer) ++ +
IPI (internal plexiform layer of the olfactory
bulb)
+ +++
Mi (mitral cell layer) ++ +
Accessory olfactory bulb
EPIA (external plexiform layer of the
accessory olfactory bulb)
++ 
MiA (mitral cell layer) ++ +
AOB (Accessory olfactory bulb) ++ +
AOD (anterior olfactory nu, dorsal) ++ +
AOE (anterior olfactory nu, external) ++ 
AOL (anterior olfactory nu, lateral) ++ +
AOM (anterior olfactory nu, med) ++ +
AOP (anterior olfactory nu, posterior) ++ +
Calleja (island of Calleja) ++ ++
DTT (dorsal tenia tecta) ++ ++
VTT (ventral tenia tecta) ++ ++
Cerebral cortex
AI (agranular insular cortex) ++ ++
Au1 (primary auditory cortex) ++ ++
AuD (auditory cortex, dorsal part) ++ ++
AuV (auditory cortex, ventral part) ++ ++
Cg1 (cingulate cortex, area2) ++ +++
Cg2 (cingulate cortex, area2) ++ +++
DI (dysgranular insular cortex) ++ ++
DIEnt (dorsal intermediate entorhinal
cortex)
++ ++
DLO (dorsolateral orbital cortex) ++ ++
DP (dorsal peduncular cortex) ++ +++
Ect (ectorhinal cortex) ++ +++
Fr3 (frontal cortex, area3) ++ ++
FrA (frontal association cortex) ++ ++
GI (granular insular cortex) ++ ++
IL (infralimbic cortex) ++ ++
LEnt (lateral entorhinal cortex) +++ +++
LO (lateral orbital cortex) ++ ++
LPtA (lateral parietal association cortex) ++ ++
M1(primary motor cortex) ++ +++
M2 (secondary motor cortex) ++ +++
MEnt (medial entorhinal cortex) +++ +++
MO (medial orbital cortex) ++ +++
MPtA (medial parietal association cortex) ++ +++
Pir (piriform cortex) +++ +++
PPtA (posterior parietal assoc area) ++ +++
PRh (perihinal cortex) ++ +++
PrL (prelimbic cortex) ++ +++
RSA (retrosplenial agranular cortex) ++ +++
RSG (retrosplenial granular cortex) ++ +++
S1 (somatosensory cortex) ++ ++
S1BF (somatosensory1, barrel ﬁeld) ++ ++
S1DZ (primary somatosensory cortex,
dysgranular zone)
++ ++
S1DZO(primary somatosensory cortex, oral
dysgranular zone)
++ ++
S1HL (primary somatosensory cortex, oral
dysgranular zone)
++ ++
S1J (somatosensory1, jaw reg) ++ ++
S1Tr (somatosensory1, trunk reg) ++ ++
Table 1 (continued)
Observed regions Intensity
S1ULp (primary somatosensory cortex,
upper lip region)
++ ++
S2 (secondary somatosensory cortex) ++ ++
TeA (temporal cortex, association a) ++ ++
V1 (primary visual cortex) ++ ++
V1B (primary visual cortex, binoc) ++ ++
V1M (primary visual cortex, binoc) ++ ++
V2L (secondary visual cortex) ++ ++
V2ML (visual cortex2, mediolat) ++ ++
V2MM (visual cortex 2, meduomed) ++ +++
VO (ventral orbital cortex) ++ ++
Hippocampus
CA1, pyramidal cell layer ++ ++
CA2/CA3, pyramidal cell layer ++ +++
FC (fasciola cinereum) ++ ++
GrDG (granular layer, dentate gyrus ++ +
LMol (lacunosum molecular layer,
hippocampus)
+ +
MoDG (molecular layer of the dentate
gyrus)
+ +
Or (oriens layer, hippocampus) + +
PoDG (polymorph layer, dentate gyrus ++ +++
Rad (stratum radiatium, hippocampus) + +
S (subiculum) ++ +++
SHi (septohippocampal nu) ++ +++
SLu (stratum lucidum, hippocampus) + +
Basal Ganglia
Cl (claustrum)  
GP (globus pallidus) ++ 
Striatum/CPU (caudate putamen) +++ +++
SN (Substantia nigra, SNC/SNR) + +
Acbc (accumbens nucleus) ++ +
Septal region
LS (lateral septal nu, LSD/LSV) ++ ++
SFi (septoﬁmbrial) ++ +
SHi (septohippocampal nu) + +
MS (medial septal nu) ++ ++
DB (nucleus of diagonal band, HDB/VDB) ++ +
BST (Bed nucleus of the stria terminalis) ++ +
HDB (nu horiz limb diagonal band) ++ +++
Amygdala
Co (anterior cortical amygdaloid nu, Aco/
PMCo)
++ ++
AHi (amygdalohipp area, AHiAL/AHiPM) ++ ++
AStr (amygdalostriation transition area) ++ ++
BL (basolat amygdaloid nu, BLA/BLV/BLP) ++ ++
BM (basomed amygdala, BMA/BMP) ++ ++
Ce (cent amygdaloid nu, CeC/CeL/CeMPV) ++ ++
I (intercalated nuclei amygdala) ++ ++
La (lat amygdaloid nu, LaDL/LaVL/LaVM) ++ ++
MeP (med amygdaloid nu, MePD/MePV) ++ ++
Dorsal Thalamus
VL (ventrolateral thalamic nu) + +
PV (paraventricular thalamic nu) + ++
MD (mediodorsal thalamic nu, MDC/MDL/
MDM)
+ ++
LD (laterodorsal thalamic nu, LDDM/LDVL) + +
VPM (ventral posteromed thalamic nu) + ++
VPL (ventral posterolat. Thalamic nu) + ++
CL (central lateral thalamic nu) + +
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Table 1 (continued)
Observed regions Intensity
SM (nucleus stria medullaris) + ++
IMD (intermediodorsal thalamic nu) + ++
Re (reuniens thalamic nu) + ++
VM (ventromed thalamic nu) + 
CM (central medial thalamic nu) + ++
SCO (subcomissural organ) + 
Dk (nu of Darkschewitsch) + ++
EW (Edinger–Westphal nu) + ++
MPO (med proptic nu, MPOM/MPOC/
MPOL)
+ ++
Epithalamus and hypothalamus
STh (subthalamic nu) + +
MHb (med habenular nu) + 
LHb (lateral habenular nu) + 
AHP (anterior hypothal area, posterior) ++ +
Arc (arcuate hypothal nu, ArcD/ArcL) + +
DM (dorsomedial hypothalamic nu) + +
LH (lateral hypothal area) + +
MM (mammillary nuclei, SuMM/MMn/LM/
SuML/LM)
++ ++
PaDC (paravent hypothal dorsal cap) ++ ++
PaLM (paravent hypothal lat magnocell) ++ ++
PaMM (paravent hypothal med magnocell) ++ ++
PaMP (paravent hypothal med parvicell) ++ ++
RCh (retrochiasmatic area) + +
TC (tuber cinereum area) + +
VMH (ventromed hypothal nu VMHDM/
VMHC/VMHVL)
+ ++
VTA (ventral tegmental area) + +
ZI (zona incerta, ZID/ZIV)  
Mesencephalon and rhombencephalon
Superior colliculus
DpG (deep gray layer, sup colliculus) + ++
InG (intermed gray layer sup colliculus) + ++
InWh (intermed white layer sup colliculus) + ++
OP (optic nerve layer sup colliculus) + +
SuG (superﬁcial gray, sup colliculus) + +
Zo (zonal layer superior colliculus) + +
Inferior colliculus
ECIC (external cortex, infer colliculus)  +
CIC (central nu inferior colliculus)  
DCIC (dorsal cortex, inferior colliculus)  
Precerebellar nu and red nu
R (red nucleus, RPC/RMC) ++ ++
PnV (pontine reticular nu) + +
Gi (gigantocellular reticular nu) + +
LPGi (lateral paragigantocellular nu) + +
DPGi (dorsal paragigantocellular nucleus) + +
Pn (pontine nuclei) + ++
PMn (paramedian reticular nu) ++ ++
LRt (lateral reticular nu) + ++
Irt (intermediate reticular nu) + ++
LSO (lateral superior olive) ++ +
LVPO (lateral ventral periolivary nu) ++ +
DPO (dorsal periolivary region) ++ +
MVPO (mediovent periolivary nu) ++ +
SPO (superior paraolivary nu) ++ +
RPO (rostral periolivary region) ++ +
Periaqueductal gray
PAG (periaqueductal gray) ++ +
Table 1 (continued)
Observed regions Intensity
DLPAG (dorsal lat periaqueductal gray) ++ +
DMPAG (dorsomed periaqueductal gray) ++ +
LPAG (lateral periaqueductal gray) ++ +
VLPAG (ventrolat periaqueductal gray) ++ +
Oromotor nuclei
Mo5 (motor nucleus of the trigeminal nerve) + +
Seven (facial nu) + +
Twelve (hypoglossal nu) + ++
Locus coeruleus
LC (locus coeruleus) ++ ++
Raphe nucleus
DR (dorsal raphe nucleus, DRC/DRD/DRI/
DRV)
+ +
Raphe nucleus pallidus (RPa) + +
Raphe nucleus obscurus (Rob) + +
ROb (raphe obscurus nu) + ++
RPa (raphe pallidus nu) + ++
DRC (dorsal raphe nu, caudal) + +
DRI (dorsal raphe nu, inferior) + +
RMg (raphe magnus nu) + +
Parabrachia nucleus
LPB (lateral parabrachial nu, LPBC/LPBD/
LPBE/LPBV)
+ +
MPB (medial parabrachial nu) + +
Tegmental Nucleus
LDTg (laterodorsal tegmental nu) + +
PDTg (posterdorsal tegmental nu) ++ ++
Vestibular nucleus
SpVe (spinal vestibular nucleus) + ++
Mve (medial vestibular nu) + ++
LVe (lateral vestibular nu) + ++
Cochlear nucleus
SGl (superﬁcial glial layer, cochlear nu) + ++
AVC (anteroventral cochlear nu) + ++
Others
IP (Interpeduncular nucleus) + +
Six abducens nu + +
Ten dorsal motor nu vagus nu ++ ++
Sol (solitary tract nu) ++ +
Me5 (mesencephalic trigeminal nucleus) + ++
Cerebellum
Molecular layer  
Purkinje cell layer ++ ++
Granular layer  
Note: Intensity of immunohistochemical staining: + ++, high; + +, moderate;
+, low;, negative. The anatomical nomenclature of Paxinos and Watson (1986)
is adopted in the most regions of the CNS.
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increased Nde1 protein levels as expected (Fig. 5A–C)
but did not aﬀect the expression of Ndel1 (Fig. 5D–F).
The same pattern was also demonstrated in Ndel1-
overexpressing cells (Fig. 5G–L). None of the empty
EGFP-vector transfected cells showed a signiﬁcant
increase in Nde1 or Ndel1 proteins (Fig. 6). Further
confocal analyses of diﬀerentiated HCN-A94 cells have
also demonstrated the speciﬁcity of the antibodies we
Fig. 5. Overexpression of Nde1 in HCN-A94 cells does not aﬀect Ndel1 expression and vice versa. HCN-A94 cells were transfected transiently with
GFP-expressing plasmids to overexpress Nde1-GFP (A–F) and Ndel1-GFP (G–L). Nde1 or Ndel1 expression was detected in addition to GFP
ﬂuorescence. Overexpression of Nde1 did not aﬀect the Ndel1 expression level (D–F). Ndel1 overexpression did not aﬀect the Nde1 protein level
(J–L). These experiments further conﬁrm the speciﬁcity of both antibodies in immunohistochemistry. Scale bar = 20 lm.
Fig. 6. Transfection of HCN-A94 cells with control pCMV-EGFP did not aﬀect the expression of endogenous Nde1 (A–C) or Ndel1 (D–F). Scale
bar = 25 lm.
128 Z. Pei et al. / Neuroscience 271 (2014) 119–136
Fig. 7. The speciﬁcity of antibodies was further demonstrated in overexpression experiments by immunocytochemistry. Cells overexpressing Nde1
(B, C, E, F) can be detected by anti-Nde1 antibody (A) but not by anti-Ndel1 antibody (D). Similarly, cells transfected with pCMV-Ndel1-EGFP (H, I,
K, L) can be identiﬁed with anti-Ndel1 (G) but not by anti-Nde1 (J). Scale bar = 10 lm.
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Ndel1 during adult stem cell diﬀerentiation, the
transfected HCN cells were diﬀerentiated for 6 days in
serum-containing medium as described before, and then
immunostained with anti b-tubulin III (Tuj1) (Fig. 8A, C,
E) and anti-GFAP (Fig. 8B, D, F). The percentage of
Tuj1/GFP-positive and GFAP/GFP-positive was
measured in transfected cells. Compared to EGFP
vector-only transfected cells, Nde1-overexpression
signiﬁcantly decreased the number of diﬀerentiatedastrocytes (P< 0.001), whereas the number of
diﬀerentiated neurons was increased slightly (Fig. 8G,
H). A smaller, but still signiﬁcant, decrease in the
number of astrocyte was observed also in Ndel1-
overexpressing cells (P< 0.05). These results strongly
suggest that the Nde1 and Ndel1 protein levels
modulate the neuron/astrocyte diﬀerentiation decision in
diﬀerentiating HCN-A94 cells and Nde1, which shows
high levels of expression in hippocampal stem cells, has
a more predominant eﬀect than Ndel1. It should be
Fig. 8. Immunohistochemistry of diﬀerentiated HCN-A94 cells. pCMV-Nde1-GFP (A, B), pCMV-Ndel1-GFP (C, D) or negative control pCMV-EGFP
(E, F) transfected HCN-A94 cells were diﬀerentiated into a mixed population of neurons and glia. The neuronal cells were identiﬁed by Tuj1 staining
(A, C, E) and the glial cells were identiﬁed by GFAP staining (B, D, F). (G, H) Percentages of the neuronal (G) and glial (H) diﬀerentiated cells were
calculated after plasmid transfection. Only GFP-expressing cells (total number: n> 15,000) were counted. ⁄P< 0.05; ⁄⁄P< 0.005; ⁄⁄⁄P< 0.001;
Scale bar = 20 lm.
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level of fusion protein produced from the plasmids is far
greater than that normally found in un-transfected HCN-
A94 cells, possibly by an order of magnitude. It is
prudent therefore to be cautious about extrapolating
these supranormal dosages to the mechanism of human
neurological disease.Fig. 9. Expression of Nde1 and Ndel1 in primary cultured neurons. (A–D)
neurons (MAP2-positive, red). Nde1 was extensively located in the cytop
expressed in the cytoplasm and nucleus and distal neurites, including growth
legend, the reader is referred to the web version of this article.)Subcellular distribution of Nde1 and Ndel1 in
cultured cells
We next examined the detailed subcellular localization of
Nde1 and Ndel1 in cultured cells. In primary cultured
neurons, we observed similar subcellular localization of
Nde1 (Figs. 9A, B and 10E, F) as in previous reportsEndogenous Nde1 and Ndel1 were detectable in primary cultured
lasm, nucleus and proximal neurites (A, B). However, Ndel1 was
cones (C, D). (For interpretation of the references to color in this ﬁgure
Fig. 10. The distribution proﬁles of Nde1 and Ndel1 in neuronal-diﬀerentiated HCN-A94 cells. (A–F) Nde1 (A, C, E) and Ndel1 (B, D, F) are both
highly expressed in neuronally-committed HCN-A94 cells after diﬀerentiation for 4 days. (D) Ndel1 also was detectable in nuclei but more obviously
expressed in the growth cones. Confocal microscopy shows the localization of Nde1 within nucleoli (E) and the perinuclear region (F). Scale
bar = 20 lm.
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sively located in the cytoplasm and nuclear or perinuclear
areas, Ndel1 was present signiﬁcantly in axonal and den-
dritic extensions as well as growth cones (Fig. 9C, D).
Similar distribution patterns were also found in neuronal-
diﬀerentiated HCN-A94 cells (Fig. 10A–F).
Astrocytes have critical roles in brain function and
tissue homeostasis and abnormalities in their function
are linked to disorders including schizophrenia and
epilepsy. Interestingly, subcellular localization of Nde1
and Ndel1 in astrocytes has not been reported before.
In light of the evidence presented above that Nde1
dosage may aﬀect astrocytic diﬀerentiation, we
performed this examination by immunocytochemistry
and detected the expression of Nde1 and Ndel1 in
primary cultured astrocytes generated from the cortex of
E18.5 mice (Fig. 11A–D). Nde1 and Ndel1 were found
to have diﬀerent subcellular localizations in astrocytes,
similar to those observed in primary cultured neurons.
While Nde1 was highly expressed in nuclei and also the
perinuclear region (Fig. 11A, B, white arrows), Ndel1
was mostly distributed in the cytoplasm, especially in
ﬁlopodial processes of astrocytes (Fig. 11C, D, white
arrows). These localization patterns broadly
recapitulated their subcellular localization in neurons.
Meanwhile, Nde1 and Ndel1 were also found inastrocytic HCN-A94 cells after diﬀerentiation (Fig. 11E–
J). It was demonstrated that Nde1 showed cytoplasmic
localization primarily in vimentin-positive cells (Fig. 11I,
J), a cell marker for immature astrocytes. Nde1 protein
level and localization therefore may change during glial
diﬀerentiation. Our results suggest that both Nde1 and
Ndel1 exist in multiple astrocytic morphological
subtypes, but their subcellular distributions do not
overlap extensively.Neuronal and astrocytic distributions of NDE1 in the
adult human cortex
Surprisingly, there is almost no histological description of
the localization of NDE1 or NDEL1 in the adult human
brain. To address this question, immunohistochemical
staining was performed on human cortical sections.
Although the Ndel1 antibody did not produce any
speciﬁc staining in these sections, we successfully
detected NDE1 in the prefrontal, frontal and temporal
lobes of the adult human cortex. NDE1 protein was
distributed in both cortical neurons (Fig. 12A–C) and
astrocytes (Fig. 12D–G). In all cortical layers, NDE1
was distributed broadly in the majority of NeuN-labeled
mature neurons, while some GFAP-expressing
astrocytes expressed NDE1 (Fig. 12E, G, white arrows).
Fig. 11. The astrocytic expression of Nde1 and Ndel1. (A, B) Immunocytochemistry on primary cultured cortical astrocytes showed the expression
of Nde1 (A, B) and Ndel1 (C, D). Nde1 was located strongly in the nuclei and also in the cytoplasm (A, B). Ndel1 was expressed extensively in
nuclei, cytoplasm and also cellular processes (C, D). (E–H) Astrocytes diﬀerentiated from HCN-A94 cells express Nde1 and Ndel1. (I, J) Nde1
protein is detectable in vimentin-positive immature astrocytes. Scale bar = 20 lm.
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contained more NDE1-positive astrocytes than white
matter (Fig. 12H). Because most gray matter astrocytes
are protoplasmic while most of the white matter
astrocytes are of the ﬁbrous type, our results suggest
that NDE1 is heterogeneously expressed in diﬀerent
astrocyte subtypes. This heterogeneous NDE1
localization was consistently found in the cortical regions
of all four donors.
qPCR experiments were then carried out to compare
the mRNA expression abundance of NDE1 and NDEL1in diﬀerent human cortical regions. The assay included
samples from the prefrontal, frontal and temporal
cortices. After normalization against controls, no
signiﬁcant variation was demonstrated among these
regions for either NDE1 or NDEL1 (Fig. 11I), suggesting
that both NDE1 and NDEL1 are widely and
homogenously expressed in the human cortex. Our
results convincingly show that NDE1 protein is
distributed widely in the human cortex, as expected, but
is localized heterogeneously in astrocytes in gray and
white matters.
Fig. 12. NDE1 distribution proﬁles in the human cortex. (A–C) Double immunolabeling of human cortical slices shows that NDE1 is distributed
extensively in NeuN-positive neurons in all layers of the cortex. Typical double-labeled neurons are indicated with white arrows. (D–G) NDE1 is also
distributed in cortical astrocytes. In gray matter, subsets of GFAP-expressing astrocytes are labeled with NDE1 (E, white arrows). (F, G) GFAP and
NDE1 double-labeled cells also were detectable in cortical white matter. (H) The proportion of NDE1-expressing astrocytes was signiﬁcantly greater
in gray than in white matter of the human cortex (10 samples from ﬁve donors; Mann–Whitney U test (P< 0.02)). (I) qPCR experiments also
revealed the mRNA expression of NDE1 and NDEL1 in the three diﬀerent cortical regions (frontal, prefrontal and temporal lobe) with no signiﬁcant
variations (n= 3). Scale bar = 20 lm.
Z. Pei et al. / Neuroscience 271 (2014) 119–136 133DISCUSSION
Neurological diseases such as schizophrenia and
epilepsy are highly complex disorders. Their etiology
and its relationship with therapeutics used for treatment
are still poorly understood. NDE1 in particular is
genetically associated with both diseases. In this study,
Nde1 and Ndel1 protein distribution and function havebeen compared in both neurons and astrocytes, to
address some outstanding questions about their cellular
and subcellular localization in the mouse and human
CNS, and to investigate possible roles in modulating the
diﬀerentiation of neurons and glia from neural stem cells.
Nde1 and Ndel1 are essential for neuronal
development and are important cell cycle regulators
(Mori et al., 2007; Kim et al., 2011). Most studies have
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including the proliferation of neural precursor cells and
neuronal migration (Bengzon et al., 1997; Sasaki et al.,
2005; Taya et al., 2007; Kim et al., 2011). Nde1 deletion
leads to cortical developmental defects (Feng and
Walsh, 2004; Pawlisz et al., 2008), and these abnormali-
ties are mostly correlated with defective embryonic neuro-
genesis. Here, we have shown that both Nde1 and Ndel1
are expressed broadly in adult mouse and human brains,
including the majority of cortical neurons. This expression
pattern of both proteins suggests that they have important
functions in mature neurons. Additionally, although Nde1
regulates radial glial functions during development
(Bengzon et al., 1997) and its function is pivotal for human
glioma formation (Suzuki et al., 2007), the astrocytic dis-
tribution of Nde1 and Ndel1 has not been investigated
extensively. We have demonstrated that Nde1 and Ndel1
are expressed in multiple subtypes of adult astrocytes
with diﬀerent morphological characteristics both in mice
and humans. Our in vitro studies further showed that
Nde1 and Ndel1 have similar subcellular localization in
astrocytes which is comparable to their distribution pat-
tern in neurons.
Based on the multi-compartmental existence of Nde1
and Ndel1 in astrocytes, together with their important
roles during cell division and spindle orientation (Feng
and Walsh, 2004), we speculate that they may be critical
for brain homeostasis and therefore contribute to a range
of disease states. Interestingly, NDE1 and NDEL1 have
been found in gliomas and their expression is highly asso-
ciated with the activity of glioma cell migration and prolif-
eration (Suzuki et al., 2007). We also found a
heterogeneous expression of NDE1 in the gray matter
and white matter of the human brain, and also in diﬀerent
sub-layers of the human cortex. These results suggest
that NDE1 is expressed selectively in certain populations
of adult cortical astrocytes, although the properties of
these astrocytic subtypes require further study.
Intriguingly, NDE1 CNV has been classiﬁed as a
potential risk factor for a series of neuronal disorders
including schizophrenia and epilepsy. Ndel1 regulates
aspects of embryonic neuronal migration and
neurogenesis and cooperates with its binding partner
DISC1 in regulating adult neurogenesis. Knockdown of
Ndel1 in the SGZ leads to abnormal soma size and
migration defects (Parent et al., 1997). In contrast, the
function of Nde1 in adult neurogenesis had not been stud-
ied. We found that Nde1 rather than Ndel1 was highly
expressed in GFAP-positive SVZ cells with radial-like pro-
cesses. This suggests Nde1 is present in SVZ-type B
stem cells. In the SGZ, Nde1, but not Ndel1, was co-local-
ized with Ki67 in actively dividing neural stem cells. These
data suggest that Nde1 is more likely than Ndel1 to be
involved in adult neural stem cell function. HCN-A94 cells
can be diﬀerentiated into a mixed cell population contain-
ing neurons and astrocytes. In this study, Nde1 overex-
pression resulted in the decreased ability of HCN-A94
cells to diﬀerentiate into astrocytes compared to the con-
trol. This suggests that Nde1 and Ndel1 may participate in
cell fate determination during adult hippocampal stem cell
diﬀerentiation and potentially links with observations ofCNV of the genes underlying human disease. Our ﬁnd-
ings are supported by previous experimental data sug-
gesting that Nde1 has an important regulatory function
in the dividing cells. This is further evidenced by the small
cerebral cortex phenotype observed in Nde1/ mice,
which was apparently caused by mitotic spindle defects
(Feng and Walsh, 2004). Our results suggest that it might
be important in future to investigate whether Nde1-over-
expressing neural stem cells have mitotic spindle defects
and how this alteration modulates their mitotic delay or
cell fate speciﬁcation.CONCLUSIONS
We have provided the most comprehensive
documentation of the expression patterns of Nde1 and
Ndel1 in cultured cells as well as in mouse and human
brains, and also highlight that dosage eﬀects of these
two proteins might contribute to some cases of mental
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